Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1019-1025
© 1996 American Heart Association, Inc.
Articles |
Regulation of Monocyte CD36 and Thrombospondin-1 Expression by Soluble Mediators
the Department of Medicine (Hematology-Oncology) and the Program in Cell Biology and Genetics (H.Y.H.), Cornell University Medical College, New York, NY.
Correspondence to Dr Roy L. Silverstein, Division of Hematology-Oncology, Cornell University Medical College, 1300 York Ave, New York, NY 10021.
Abstract
CD36 is an 88-kD integral membrane protein expressed on platelets, monocytes, macrophages, certain microvascular endothelia, and retinal pigment epithelium. It functions as an adhesive receptor for thrombospondin-1 (TSP-1), collagen, and malaria-infected erythrocytes and as a scavenger receptor for oxidized LDL and photoreceptor outer segments. The CD36–TSP-1 interaction plays a role in cell adhesion and the phagocytosis of apoptotic cells by macrophages. Because of the potential importance of the CD36–TSP-1 interaction in mediating atherogenic and inflammatory processes, we studied their expression in human peripheral blood monocytes exposed to soluble mediators known to regulate inflammation and atherogenesis. RNase protection assays showed 6- to 12-fold increases in CD36 mRNA in response to interleukin-4, monocyte colony-stimulating factor, and phorbol myristate acetate, while lipopolysaccharide and dexamethasone strongly downregulated CD36 mRNA. The downregulation of CD36 mRNA was associated with the disappearance of surface expression of CD36 antigen and loss of TSP-1 surface-binding capacity. Upregulation of CD36 mRNA was associated with a modest increase in surface antigen expression and a larger expansion of an intracellular pool of CD36. As with CD36, monocytes treated with monocyte colony-stimulating factor showed a rapid increase in TSP-1 mRNA expression. Moreover, while dexamethasone treatment decreased CD36 expression, it resulted in a rapid increase in TSP-1 mRNA, and while PMA increased CD36 mRNA, it rapidly decreased TSP-1 expression. Interferon gamma, which had no effect on CD36 mRNA, rapidly increased steady-state TSP-1 mRNA. Thus, expression of both CD36 and its ligand TSP-1 is regulated by soluble mediators, although certain mediators induce concordant changes and others discordant changes.
Key Words: CD36 • thrombospondin-1 • scavenger receptor • cytokine • monocyte
This article has been cited by other articles:
 |
|
 |
|
  R. Shaykhiev, A. Krause, J. Salit, Y. Strulovici-Barel, B.-G. Harvey, T. P. O'Connor, and R. G. Crystal Smoking-Dependent Reprogramming of Alveolar Macrophage Polarization: Implication for Pathogenesis of Chronic Obstructive Pulmonary Disease J. Immunol., August 15, 2009; 183(4): 2867 - 2883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Okamura, S. Pennathur, K. Pasichnyk, J. M. Lopez-Guisa, S. Collins, M. Febbraio, J. Heinecke, and A. A. Eddy CD36 Regulates Oxidative Stress and Inflammation in Hypercholesterolemic CKD J. Am. Soc. Nephrol., March 1, 2009; 20(3): 495 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Helming, J. Winter, and S. Gordon The scavenger receptor CD36 plays a role in cytokine-induced macrophage fusion J. Cell Sci., February 15, 2009; 122(4): 453 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Lu, L. Li, K. Kuno, Y. Wu, T. Baba, Y.-y. Li, X. Zhang, and N. Mukaida Protective Roles of the Fractalkine/CX3CL1-CX3CR1 Interactions in Alkali-Induced Corneal Neovascularization through Enhanced Antiangiogenic Factor Expression J. Immunol., March 15, 2008; 180(6): 4283 - 4291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Okamura, J. M. Lopez-Guisa, K. Koelsch, S. Collins, and A. A. Eddy Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury Am J Physiol Renal Physiol, August 1, 2007; 293(2): F575 - F585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Collot-Teixeira, J. Martin, C. McDermott-Roe, R. Poston, and J. L. McGregor CD36 and macrophages in atherosclerosis Cardiovasc Res, August 1, 2007; 75(3): 468 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yanai, I. Watanabe, K. Ishii, M. Morimoto, H. Fujiwara, S. Yoshida, S.-P. Hui, K. Matsuno, and H. Chiba Attenuated aerobic exercise capacity in CD36 deficiency J. Med. Genet., July 1, 2007; 44(7): 445 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ehrchen, L. Steinmuller, K. Barczyk, K. Tenbrock, W. Nacken, M. Eisenacher, U. Nordhues, C. Sorg, C. Sunderkotter, and J. Roth Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes Blood, February 1, 2007; 109(3): 1265 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Avallone, A. Demers, A. Rodrigue-Way, K. Bujold, D. Harb, S. Anghel, W. Wahli, S. Marleau, H. Ong, and A. Tremblay A Growth Hormone-Releasing Peptide that Binds Scavenger Receptor CD36 and Ghrelin Receptor Up-Regulates Sterol Transporters and Cholesterol Efflux in Macrophages through a Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Pathway Mol. Endocrinol., December 1, 2006; 20(12): 3165 - 3178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Puig-Kroger, A. Dominguez-Soto, L. Martinez-Munoz, D. Serrano-Gomez, M. Lopez-Bravo, E. Sierra-Filardi, E. Fernandez-Ruiz, N. Ruiz-Velasco, C. Ardavin, Y. Groner, et al. RUNX3 Negatively Regulates CD36 Expression in Myeloid Cell Lines J. Immunol., August 15, 2006; 177(4): 2107 - 2114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Ikonomidis, G. Athanassopoulos, J. Lekakis, K. Venetsanou, M. Marinou, K. Stamatelopoulos, D. V. Cokkinos, and P. Nihoyannopoulos Myocardial Ischemia Induces Interleukin-6 and Tissue Factor Production in Patients With Coronary Artery Disease: A Dobutamine Stress Echocardiography Study Circulation, November 22, 2005; 112(21): 3272 - 3279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sezaki, S. Hirohata, A. Iwabu, K. Nakamura, K. Toeda, T. Miyoshi, H. Yamawaki, K. Demircan, S. Kusachi, Y. Shiratori, et al. Thrombospondin-1 Is Induced in Rat Myocardial Infarction and Its Induction Is Accelerated by Ischemia/Reperfusion Experimental Biology and Medicine, October 1, 2005; 230(9): 621 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Daugherty, N. R. Webb, D. L. Rateri, and V. L. King Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis J. Lipid Res., September 1, 2005; 46(9): 1812 - 1822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Febbraio, E. Guy, and R. L. Silverstein Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2333 - 2338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Antonov, F. D. Kolodgie, D. H. Munn, and R. G. Gerrity Regulation of Macrophage Foam Cell Formation by {alpha}V{beta}3 Integrin: Potential Role in Human Atherosclerosis Am. J. Pathol., July 1, 2004; 165(1): 247 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Ikonomidis, F Andreotti, and P Nihoyannopoulos Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor Heart, April 1, 2004; 90(4): 389 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kanters, M. J.J. Gijbels, I. van der Made, M. N. Vergouwe, P. Heeringa, G. Kraal, M. H. Hofker, and M. P. J. de Winther Hematopoietic NF-{kappa}B1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype Blood, February 1, 2004; 103(3): 934 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. OSTERUD and E. BJORKLID Role of Monocytes in Atherogenesis Physiol Rev, October 1, 2003; 83(4): 1069 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Davenport and P. G. Tipping The Role of Interleukin-4 and Interleukin-12 in the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice Am. J. Pathol., September 1, 2003; 163(3): 1117 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Sato, C. Kuriki, Y. Fukui, and K. Motojima Dual Promoter Structure of Mouse and Human Fatty Acid Translocase/CD36 Genes and Unique Transcriptional Activation by Peroxisome Proliferator-activated Receptor alpha and gamma Ligands J. Biol. Chem., May 3, 2002; 277(18): 15703 - 15711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Akiyama, S. Sakai, G. Lambert, C. J. Nicol, K. Matsusue, S. Pimprale, Y.-H. Lee, M. Ricote, C. K. Glass, H. B. Brewer Jr., et al. Conditional Disruption of the Peroxisome Proliferator-Activated Receptor {gamma} Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux Mol. Cell. Biol., April 15, 2002; 22(8): 2607 - 2619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. King, S. J. Szilvassy, and A. Daugherty Interleukin-4 Deficiency Decreases Atherosclerotic Lesion Formation in a Site-Specific Manner in Female LDL Receptor-/- Mice Arterioscler Thromb Vasc Biol, March 1, 2002; 22(3): 456 - 461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. S. Coraci, J. Husemann, J. W. Berman, C. Hulette, J. H. Dufour, G. K. Campanella, A. D. Luster, S. C. Silverstein, and J. B. El Khoury CD36, a Class B Scavenger Receptor, Is Expressed on Microglia in Alzheimer's Disease Brains and Can Mediate Production of Reactive Oxygen Species in Response to {beta}-Amyloid Fibrils Am. J. Pathol., January 1, 2002; 160(1): 101 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Hansson Immune Mechanisms in Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1876 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kaplan and M. Aviram Retention of Oxidized LDL by Extracellular Matrix Proteoglycans Leads to Its Uptake by Macrophages : An Alternative Approach to Study Lipoproteins Cellular Uptake Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 386 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Feng, J. Han, S. F. A. Pearce, R. L. Silverstein, A. M. Gotto , Jr., David. P. Hajjar, and A. C. Nicholson Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-{gamma} J. Lipid Res., May 1, 2000; 41(5): 688 - 696. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Peiser, P. J. Gough, T. Kodama, and S. Gordon Macrophage Class A Scavenger Receptor-Mediated Phagocytosis of Escherichia coli: Role of Cell Heterogeneity, Microbial Strain, and Culture Conditions In Vitro Infect. Immun., April 1, 2000; 68(4): 1953 - 1963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Cornicelli, D. Butteiger, D. L. Rateri, K. Welch, and A. Daugherty Interleukin-4 augments acetylated LDL-induced cholesterol esterification in macrophages J. Lipid Res., March 1, 2000; 41(3): 376 - 383. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Miyajima–Uchida, H. Hayashi, R. Beppu, M. Kuroki, M. Fukami, F. Arakawa, Y. Tomita, M. Kuroki, and K. Oshima Production and Accumulation of Thrombospondin-1 in Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 561 - 567. [Abstract] [Full Text]
|
|
|
|
|
|
J. Han, D. P. Hajjar, J. M. Tauras, J. Feng, A. M. Gotto Jr., and A. C. Nicholson Transforming Growth Factor-beta 1 (TGF-beta 1) and TGF-beta 2 Decrease Expression of CD36, the Type B Scavenger Receptor, through Mitogen-activated Protein Kinase Phosphorylation of Peroxisome Proliferator-activated Receptor-gamma J. Biol. Chem., January 14, 2000; 275(2): 1241 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Panousis and S. H. Zuckerman Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-{gamma} J. Lipid Res., January 1, 2000; 41(1): 75 - 83. [Abstract] [Full Text]
|
|
|
|
|
|
T. Yehualaeshet, R. O'Connor, J. Green-Johnson, S. Mai, R. Silverstein/p, J. E. Murphy-Ullrich, and N. Khalil Activation of Rat Alveolar Macrophage-Derived Latent Transforming Growth Factor {beta}-1 by Plasmin Requires Interaction with Thrombospondin-1 and its Cell Surface Receptor, CD36 Am. J. Pathol., September 1, 1999; 155(3): 841 - 851. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Ikonomidis, F. Andreotti, E. Economou, C. Stefanadis, P. Toutouzas, and P. Nihoyannopoulos Increased Proinflammatory Cytokines in Patients With Chronic Stable Angina and Their Reduction By Aspirin Circulation, August 24, 1999; 100(8): 793 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Draude, P. von Hundelshausen, M. Frankenberger, H. W. L. Ziegler-Heitbrock, and C. Weber Distinct scavenger receptor expression and function in the human CD14+/CD16+ monocyte subset Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1144 - H1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. E. de Vries, B. Buchner, T. J. C. van Berkel, and J. Kuiper Specific Interaction of Oxidized Low-Density Lipoprotein With Macrophage-Derived Foam Cells Isolated From Rabbit Atherosclerotic Lesions Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 638 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kume, T. Murase, H. Moriwaki, T. Aoyama, T. Sawamura, T. Masaki, and T. Kita Inducible Expression of Lectin-like Oxidized LDL Receptor-1 in Vascular Endothelial Cells Circ. Res., August 10, 1998; 83(3): 322 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakagawa, S. Nozaki, M. Nishida, J. M. Yakub, Y. Tomiyama, A. Nakata, K. Matsumoto, T. Funahashi, K. Kameda-Takemura, Y. Kurata, et al. Oxidized LDL Increases and Interferon-{gamma} Decreases Expression of CD36 in Human Monocyte–Derived Macrophages Arterioscler Thromb Vasc Biol, August 1, 1998; 18(8): 1350 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yoshida, O. Quehenberger, N. Kondratenko, S. Green, and D. Steinberg Minimally Oxidized Low-Density Lipoprotein Increases Expression of Scavenger Receptor A, CD36, and Macrosialin in Resident Mouse Peritoneal Macrophages Arterioscler Thromb Vasc Biol, May 1, 1998; 18(5): 794 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Han, D. P. Hajjar, M. Febbraio, and A. C. Nicholson Native and Modified Low Density Lipoproteins Increase the Functional Expression of the Macrophage Class B Scavenger Receptor, CD36 J. Biol. Chem., August 22, 1997; 272(34): 21654 - 21659. [Abstract] [Full Text] [PDF]
|
|